Keisuke Tamari

8PUBLICATIONS
19CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Preventative health careRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 14, 2025
Regional disparities in IMRT utilization in Japan: analysis of trends and associated medical resources from 2015 to 2019†.

Keisuke Tamari, Yuna Kumoyama, Hodaka Numasaki

|Oct 30, 2023
The impact of the COVID-19 pandemic on radiotherapy delivery in Japan: An observational study based on the national database.

Keisuke Tamari, Maiko Kishigami, Yasushi Nagata

|May 19, 2023
Increased toxicities associated with dose escalation of stereotactic body radiation therapy in prostate cancer: results from a phase I/II study.

Takero Hirata, Osamu Suzuki, Keisuke Otani

|Dec 17, 2021
Poly (ADP-ribose) polymerase inhibitors sensitize cancer cells to hypofractionated radiotherapy through altered selection of DNA double-strand break repair pathways.

Yuji Seo, Keisuke Tamari, Yutaka Takahashi

|Aug 03, 2021
Successful High-Dose Radiation Treatment for Chemo-Resistant Oral Squamous Cell Carcinoma in a Kindler's Syndrome Patient.

Yuka Kimura, Atsushi Tanemura, Yuma Hanaoka

|Jan 07, 2021
Monitoring expiratory carbon monoxide to study the effect of complete smoking cessation on definitive radiation therapy for early stage glottic carcinoma.

Shotaro Tatekawa, Shigetoshi Shimamoto, Yoshiaki Miyata

Pageof 2

Frequent Collaborators

2 joint publications

Shotaro Tatekawa

2 joint publications

Yuji Seo

1 joint publications

Zhihao Li

1 joint publications

Katsutoshi Sato